68Ga-DOTATOC PET/CT-Based Radiomic Analysis and PRRT Outcome: A Preliminary Evaluation Based on an Exploratory Radiomic Analysis on Two Patients

Frontiers in Medicine

Filippo Molinari¹  Bruno De Santi¹  Alessandro Piovesan²  Libero Ciuffreda³  Elena Gallio⁴  Osvaldo Rampado⁴  Federica Fioroni⁵  Annibale Versari⁶  Beatrice Dionisi⁷  Virginia Liberini⁷  Désirée Deandreis⁷  Francesco Ceci⁷  Philippe Thuillier⁸ 

[1] Biolab, Department of Electronics and Telecommunications, Politecnico di Torino, Turin, Italy;Division of Oncological Endocrinology, Department of Medical Sciences, University of Turin, Turin, Italy;Medical Oncology Division 1, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, University of Turin, Turin, Italy;Medical Physics Unit, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Turin, Italy;Medical Physics Unit, Azienda Unit Sanitaria Locale di Reggio Emilia - Istituto di Ricovero e Cura a Carattere Scientifico of Reggio Emilia, Reggio Emilia, Italy;Nuclear Medicine Unit, Azienda Unit Sanitaria Locale di Reggio Emilia - Istituto di Ricovero e Cura a Carattere Scientifico of Reggio Emilia, Reggio Emilia, Italy;Nuclear Medicine Unit, Department of Medical Sciences, University of Turin, Turin, Italy;Nuclear Medicine Unit, Department of Medical Sciences, University of Turin, Turin, Italy;Department of Endocrinology, University Hospital of Brest, Brest, France;

关键词: Ga-DOTATOC PET/CT;    peptide receptor radionuclide therapy;    radiomic analysis;    NET;    total lesion somatostatin receptor expression;    somatostatin receptor expressing tumor volume;   

DOI  :  10.3389/fmed.2020.601853

来源: Frontiers

【 授权许可】

CC BY